Travel Medicine and Infectious Disease
Volume 8, Issue 1 , Pages 22-28, January 2010

Cough and dyspnoea of an asthmatic patient at Mt. Kilimanjaro: A difficult differential diagnosis

  • K. Goebbels

      Affiliations

    • Institute of Occupational and Social Medicine, RWTH Aachen University, Aachen, Germany
  • ,
  • U. Gieseler

      Affiliations

    • Department for Internal Medicine, Diakonissenkrankenhaus Speyer, Germany
    • Medical Commission of the Union Internationale des Associations d'Alpinisme (UIAA MedCom), Bern, Switzerland
  • ,
  • Volker Schöffl

      Affiliations

    • Medical Commission of the Union Internationale des Associations d'Alpinisme (UIAA MedCom), Bern, Switzerland
    • Department of Trauma and Orthopaedic Surgery, Klinikum Bamberg, Germany
  • ,
  • Thomas Küpper

      Affiliations

    • Institute of Occupational and Social Medicine, RWTH Aachen University, Aachen, Germany
    • Medical Commission of the Union Internationale des Associations d'Alpinisme (UIAA MedCom), Bern, Switzerland
    • Corresponding Author InformationCorresponding author. Allmendenweg 52, D-40221 Düsseldorf, Germany. Tel.: +49 1520 1820256.

Received 3 August 2009; received in revised form 27 October 2009; accepted 2 November 2009. published online 14 December 2009.

Summary 

This case highlights the difficulties associated with the differential diagnosis of pulmonary symptoms in patients with pre-existing diseases in extreme environmental conditions. A 58-year-old man with child-onset allergic asthma developed dyspnoea and an acute non-productive cough during a trekking expedition on Mt. Kilimanjaro (5895m) in Tanzania. The symptoms were believed initially to be linked to the high altitude exposure (high altitude pulmonary oedema (HAPE) or high altitude cough) or his pre-existing asthma. However, he was later diagnosed correctly with a reinfection of Bordetella pertussis. Pertussis is a highly communicable disease with potentially serious medical consequences that could have affected all of the expedition members. The effectiveness of a pertussis vaccine declines 4–12 years after the vaccination. Thus, it is suggested that the status of immunisation against pertussis should be checked along with those of other infections prior to travel.

Keywords: Asthma, Bronchitis, High altitude pulmonary oedema (HAPE), High altitude cough, Pertussis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1477-8939(09)00157-4

doi:10.1016/j.tmaid.2009.11.001

Travel Medicine and Infectious Disease
Volume 8, Issue 1 , Pages 22-28, January 2010